Study of SHR-3167 for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an experimental drug called SHR-3167 in people with type 2 diabetes. The goal is to see how the drug works in the body and how it affects blood sugar. It may be an option for adults who have had diabetes for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 59 years old.
- You must have been diagnosed with type 2 diabetes for at least 6 months.
- You must not have poorly controlled high blood pressure.
- You must not have serious heart or blood vessel problems in the last 6 months.
- You must not have a history of severe drug or food allergies.
- You must not have hepatitis B, hepatitis C, HIV, or syphilis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, HS-20094, for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This trial tests an investigational medication (HS-20094) for people with type 2 diabetes. It aims to see if it can help control blood sugar and possibly support weight loss.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.